enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Phenylbiguanide - Wikipedia

    en.wikipedia.org/wiki/Phenylbiguanide

    Phenylbiguanide (PBG) is a 5-HT3 agonist used to study the role of 5-HT3 receptors in the central nervous system. [1] It has been found to trigger dopamine release in the nucleus accumbens of rats. [ 2 ]

  3. Biguanide - Wikipedia

    en.wikipedia.org/wiki/Biguanide

    Biguanide (/ b aɪ ˈ ɡ w ɒ n aɪ d /) is the organic compound with the formula HN(C(NH)NH 2) 2. It is a colorless solid that dissolves in water to give a highly basic solution. It is a colorless solid that dissolves in water to give a highly basic solution.

  4. 2,5-Dimethoxy-4-sec-butylamphetamine - Wikipedia

    en.wikipedia.org/wiki/2,5-Dimethoxy-4-sec-butyl...

    [1] [2] [7] For comparison, the affinities of LSD and DOM in the same study were 6.31 nM and 18.6 nM, respectively. [7] DOSB substitutes for LSD in rodent drug discrimination tests, albeit much less potently than DOM ( ED 50 Tooltip median effective dose = 1.80 mg/kg versus 0.148 mg/kg, respectively; ~12-fold difference) and with only partial ...

  5. Chlorophenylbiguanide - Wikipedia

    en.wikipedia.org/wiki/Chlorophenylbiguanide

    meta-Chlorophenylbiguanide (1-(3-Chlorophenylbiguanide, m-CPBG) is an allosteric agonist and modulator of the 5-HT 3 receptor [1] [2] [3] and an antagonist of the α 2A-adrenergic receptor. [4] It has anxiogenic , emetic and hypothermic effects in animal studies.

  6. BMB-201 - Wikipedia

    en.wikipedia.org/wiki/BMB-201

    Conversely, BMB-A39a shows minimal or negligible activity in activating the serotonin 5-HT 2B receptor (E max < 20%) and does not activate other serotonin receptors. [ 3 ] [ 4 ] BMB-201 is said to have minimal or absent psychedelic effects due to its reduced serotonin 5-HT 2A receptor intrinsic activity but to potently induce neuroplasticity .

  7. VU0530244 - Wikipedia

    en.wikipedia.org/wiki/VU0530244

    VU0530244 is a potent, selective, and putatively peripherally restricted serotonin 5-HT 2B receptor antagonist which was first described in 2023. [1] [2] [3] Another similar drug, VU0631019, was also described alongside VU0530244. [3]

  8. Category:Biguanides - Wikipedia

    en.wikipedia.org/wiki/Category:Biguanides

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  9. Flupentixol - Wikipedia

    en.wikipedia.org/wiki/Flupentixol

    A study measuring the in vivo receptor occupancies of 13 schizophrenic patients treated with 5.7 ± 1.4 mg/day of flupentixol found 50-70% receptor occupancy for D2, 20 ± 5% for D1, and 20 ± 10% for 5-HT2A.